The Effect of Highly Active Antiretroviral Therapy-Induced Immune Reconstitution on Development and Outcome of Progressive Multifocal Leukoencephalopathy: Study of 43 Cases with Review of the Literature

References

• Antinori A, A=assari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A (2001). Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J NeuroVirol 7: 323–328.
   PubMed Web of Science ®Google Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predic-tive factors for prolonged survival in acquired immun-odeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.
   Google Scholar
• Cinque P, Pierotti C, Vigano MG, Bestetti A, Fausti C, Bertelli D, Lazzarin A (2001). The good and evil of HAART in HIV-related progressive multifocal leukoen-cephalopathy. J NeuroVirol 7: 358–363.
   Google Scholar
• Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fomara C, Racca S, Castagna A, D'Arminio Monforte A, Wahren B, Lazzarin A, Linde A (1996). Polymerase chain re-action on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951–958.
   Google Scholar
• Collazos J, Mayo J, Martinez E, Blanco MS (1999). Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 13: 1426–1428.
   Google Scholar
• Cooney EL (2002). Clinical indicators of immune restora-tion following highly active antiretroviral therapy. Clin Infect Dis 34: 224–233.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, A=assari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A (2001). Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. J Neuro-Virol 7: 364–368.
   Google Scholar
• DeSimone JA, Pomerantz RJ, Babinchak TJ (2000). Inflam-matory reactions in HIV-1-infected persons after initia-tion of highly active antiretroviral therapy. Ann Intern Med 133: 447–454.
   Google Scholar
• Garcia De Viedma D, Diaz Infantes M, Miralles P, Berenguer J, Mann M, Munoz L, Bouza E (2002). JC virus load in multifocal progressive leukoencephalopathy: anal-ysis of the correlation between the viral burden in cerebrospinal fluid, patient survival and the volume of neurological lesions. Clin Infect Dis 34: 1568–1575.
   Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifo-cal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
   Google Scholar
• Koralnik IJ, Du Pasquier RA, Kuroda MJ, Schmitz JE, Dang X, Zheng Y, Lifton M, Letvin NL (2002). Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response spe-cific for a commonly recognized JC virus epitope. JIm-muno1168: 499–504.
   Google Scholar
• Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS (1998). Enhancing progressive multifocal leukoen-cephalopathy: an indicator of improved immune status? Am J Med 105: 541–543.
   Google Scholar
• Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver 5 (2002). A pilot study of cidofovir for progressive multifocal leukoen-cephalopathy in AIDS. AIDS 16: 1791–1797.
   Google Scholar
• Mayo J, Collazos J, Martinez E (1998). Progressive multifo-cal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS 12: 1720–1722.
   Google Scholar
• Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001). Inflammatory reactions in progressive multifocal leukoencephalopa-thy after highly active antiretroviral therapy. AIDS 15: 1900–1902.
   Google Scholar
• Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atrnar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002). Immune reconsti-tution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213–227.
   Google Scholar
• Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1999). Progressive multifocal leukoen-cephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152–1154.
   Google Scholar
• Thumher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E (2001). Initial and follow-up MR imag-ing findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active an-tiretroviral therapy. AJNR Am J Neuromdiol 22: 977–984.
   Google Scholar
• Woo HH, Rezai AR, Knopp EA, Weiner HL, Miller DC, Kelly PJ (1996). Contrast-enhancing progressive multifo-cal leukoencephalopathy: radiological and pathological correlations: case report. Neurosurgery 39: 1031–1034; discussion, 1034–1035.
   Google Scholar
• Yiannoutsos CT, Major EO, Curfrnan B, Jensen PN, Gravell M, Hou J, Clifford DB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to sur-vival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoen-cephalopathy. Ann Neurol 45: 816–821.
   Google Scholar